Improving follow-up rates in spontaneous adverse drug reaction reporting: Effectiveness of a targeted letter used by a regional centre in the UK

Drug Safety

Volumn 32, Issue 12, 2009, Pages 1135-1140

  Anton, Christopher ^a   Cox, Anthony R ^a,b   Ferner, Robin E ^a  

^a SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE DRUG REACTION; ARTICLE; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; DRUG TARGETING; FOLLOW UP; PRIORITY JOURNAL; UNITED KINGDOM;

ADVERSE DRUG REACTION REPORTING SYSTEMS; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS;

EID: 70449724745     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11318940-000000000-00000     Document Type: Article

References (11)

1. Olivier P, Montastruc JL. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France. Pharmacoepidemiol Drug Saf 2006; 15 (11): 808-812
2. Clarke A, Deeks J, Shakir SAW. An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets. Drug Saf 2006; 29 (2): 175-181
3. Hauben M, Aronson JK. Gold standards in pharmaco-vigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore. Drug Saf 2007; 30 (8): 645-655
4. Blenkinsopp A, Wilkie P, Wang M, et al. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol 2006; 63 (2): 148-156
5. Evans SJW, Waller PC, Davis S. Use of proportional report-ing ratios (PRRs) for signal generation from spontaneous adverse drug reactions. Pharmacoepidemiol Drug Saf 2001; 10: 483-486
6. Arnaiz JA, Carne X, Riba N, et al. The use of evidence in pharmacovigilance: case reports as the reference source for drug withdrawals. Eur J Clin Pharmacol 2001; 57 (1): 89-91
7. Report of CIOMS Working Group V. Current challenges in pharmacovigilance: pragmatic approaches. Geneva: CIOMS, 2001
8. Inman WHW. Assessment of drug safety problems. In: Gent M, Shigamatsu I, editors. Epidemiological issues in reported drug-induced illnesses: proceedings of an international symposium held on 19th-21st January 1976 in the East-West Centre, Honolulo. 1st ed. Hamilton (ON): McMaster University Library Press, 1978: 17-24
9. Belton KJ, Lewis SC, Payne S, et al. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol 1995; 39: 223-226
10. Martin RM, Kapoor KV, Wilton LV, et al. Underreporting of suspected adverse drug reactions to newly marketed (''black triangle'') drugs in general practice: observational study. BMJ 1998; 317: 119-120
11. Cornelissen L, van Puijenbroek E, van Grootheest K. Expec-tations of general practitioners and specialist doctors regarding the feedback received after reporting an adverse drug reaction. Pharmacoepidemiol Drug Saf 2007; 17: 76-81